期刊文献+

蛋白质组学与转化医学:用以癌症诊断、预后和疗效预测的分子生物标记物 被引量:9

Proteomics and Translational Medicine:Molecular Biomarkers for Cancer Diagnosis,Prognosis and Prediction of Therapy Outcome
暂未订购
导出
摘要 “生物医学研究的最新技术进展使鉴定多种分子生物标记物变得更加容易,有助于促进癌症筛查和检测……通过允许医生为患者制定个体化治疗来提高癌症治疗的有效性和安全性。”
出处 《中国肺癌杂志》 CAS 2011年第8期I0003-I0006,共4页 Chinese Journal of Lung Cancer
  • 相关文献

参考文献1

二级参考文献33

  • 1Cho WC. Conquering cancer through discovery research. IUBMB Life 62(9), 655-659 (2010).
  • 2Cho WC. Cancer biomarkers (an overview). In: Methods of Cancer Diagnosis, Therapy and Prognosis (Volume 7). Hayat MA (Ed.). Springer, Berlin, Germany 21-40 (2010).
  • 3Goto Y, Koyanagi K, Narita Net al. Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma. ]. Invest. Dermatol. 130(1), 221-229 (2010).
  • 4Wang H, Yan H, Fu Aet al. TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation. PLoS ONE 5(8), el20S1 (2010).
  • 5de Jong MC, Pramana J, van der WalJE et al. CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin. Cancer Res. 16(21), 5329-5338 (2010).
  • 6Daskalaki A, Agelaki S, Perraki Met al. Detection of cytokeratin-i9 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer. Br. J. Cancer 101(4), 589-597 (2009).
  • 7Xenidis N, Ignatiadis M, Apostolaki S et al. Cytokeratin-19 mRNA- positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J. Clin. Oneol. 27(13), 2177-2184 (2009).
  • 8Bass MB, Sherman SI, Schlumberger MJ et al. Biomarkers as predictors of response to treatment with motesanib in patients with progressive advanced thyroid cancer. J. Clin. Endocrinol. Metab. 95(11), 5018-5027 (2010).
  • 9Koyanagi K, O'Day SJ, Boasberg Pet al. Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma. Clin. CancerRes. 16(8), 2402-2408 (2010).
  • 10Zuo Z, Jones D, Yao H et al. A pathway-based gene signature correlates with therapeutic response in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Mod. Pathol. 23 (11), 1524-1534 (2010).

共引文献14

同被引文献67

  • 1刘新,戴朴,黄德亮,袁慧军,李为民,曹菊阳,于飞,张锐宁,林红艳,朱秀辉,何勇,虞幼军,姚昆.线粒体DNAA1555G突变大规模筛查及其预防意义探讨[J].中华医学杂志,2006,86(19):1318-1322. 被引量:120
  • 2袁永一,黄德亮,戴朴,朱庆文,刘新,王国建,李琦,吴柏林.中国非综合征遗传性聋人群GJB6基因突变分析[J].临床耳鼻咽喉头颈外科杂志,2007,21(1):3-6. 被引量:12
  • 3祝世讷.失调——揭示“关系失调为病”的机制[J].山东中医药大学学报,2007,31(4):267-269. 被引量:8
  • 4徐婉珍,孙芳芳,苏京平.以转化医学理念指导临床人才培养[J].中华医院管理杂志,2010,26(2):150-153.
  • 5Sava G, Bergamo A, Dyson P J. Metal-based antitumo: drugs in the post-genomic era: What comes next? [J]. Dalton Transactions, 2011,40 (36) :9069-9075.
  • 6Brustad E M, Arnold F H. Optimizing non-natural protein function with directed evolution [ J ]. Current Opinion in Chemical Biology, 2011,15 (2) :201-210.
  • 7Heo M, Maslov S, Shakhnovich E. Topology of protein in- teraction network shapes protein abundances and strengths of their functional and nonspecific interactions [ J ]. Pro- ceedings of the National Academy of Sciences, 2011,108 (10) : 4258-4263.
  • 8Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: Application to cancer genom- ies[J]. Nucleic Acids Research, 2011,39(17) :ellS.
  • 9Stynen B, Tournu H, Tavernier J, et al. Diversity in ge- netic in vivo methods for protein-protein interaction stud- ies: From the yeast two-hybrid system to the mammalian split-luciferase system[ J ]. Microbiology and Molecular Bi- ology Reviews, 2012,76 ( 2 ) : 331-382.
  • 10Raimondo F, Morosi L, Chinello C, et al. Advances in membranous vesicle and exosome proteomics improving bio- logical understanding and biomarker discovery [ J ]. Pro- teomics, 2011,11 (4) :709-720.

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部